Janiczek Wealth Management LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 24.6% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,084 shares of the healthcare conglomerate’s stock after buying an additional 214 shares during the quarter. Janiczek Wealth Management LLC’s holdings in UnitedHealth Group were worth $521,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Axiom Financial Strategies LLC purchased a new position in shares of UnitedHealth Group during the 1st quarter valued at about $210,000. McGowan Group Asset Management Inc. boosted its position in UnitedHealth Group by 8.9% in the 1st quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock worth $379,000 after purchasing an additional 61 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of UnitedHealth Group by 31.8% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock valued at $127,592,000 after purchasing an additional 60,300 shares in the last quarter. MAS Advisors LLC boosted its holdings in UnitedHealth Group by 10.8% during the first quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock worth $241,000 after buying an additional 45 shares in the last quarter. Finally, First Western Trust Bank purchased a new position in UnitedHealth Group in the first quarter valued at $875,000. Hedge funds and other institutional investors own 85.69% of the company’s stock.
UnitedHealth Group Stock Down 0.1 %
Shares of NYSE UNH opened at $486.06 on Tuesday. The company has a market capitalization of $450.24 billion, a P/E ratio of 21.75, a P/E/G ratio of 1.43 and a beta of 0.66. UnitedHealth Group Incorporated has a 1 year low of $445.68 and a 1 year high of $558.10. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.80 and a quick ratio of 0.80. The company has a 50 day simple moving average of $492.05 and a 200-day simple moving average of $486.73.
UnitedHealth Group Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Monday, September 11th will be paid a $1.88 dividend. The ex-dividend date of this dividend is Friday, September 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s payout ratio is presently 33.65%.
Insider Buying and Selling at UnitedHealth Group
In other UnitedHealth Group news, CEO Andrew Witty sold 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, July 19th. The shares were sold at an average price of $506.19, for a total value of $2,024,760.00. Following the completion of the transaction, the chief executive officer now owns 78,573 shares of the company’s stock, valued at approximately $39,772,866.87. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.35% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
UNH has been the subject of several recent analyst reports. JPMorgan Chase & Co. lifted their price target on UnitedHealth Group from $527.00 to $532.00 and gave the company an “overweight” rating in a research note on Monday, July 17th. Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $616.00 to $561.00 in a research note on Thursday, July 13th. Truist Financial decreased their price objective on shares of UnitedHealth Group from $610.00 to $580.00 in a report on Wednesday, June 14th. StockNews.com began coverage on shares of UnitedHealth Group in a research note on Thursday, August 17th. They issued a “buy” rating on the stock. Finally, Sanford C. Bernstein upgraded UnitedHealth Group from a “market perform” rating to an “outperform” rating and raised their target price for the company from $595.00 to $603.00 in a research report on Tuesday, July 18th. Two equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $575.65.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
- Five stocks we like better than UnitedHealth Group
- What is Short Interest? How to Use It
- 2 Recession-Proof Intelligence Stocks to Defend Your Portfolio
- EV Stocks and How to Profit from Them
- 5 Reasons Mullen Automotive is About to Turn a Corner
- What Are Utility Stocks? An Overview of the Utilities Sector
- Qualcomm and Apple Forge Ahead with New Modem Partnership
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.